182 related articles for article (PubMed ID: 29089194)
21. Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice.
Ophorst OJ; Radosević K; Havenga MJ; Pau MG; Holterman L; Berkhout B; Goudsmit J; Tsuji M
Infect Immun; 2006 Jan; 74(1):313-20. PubMed ID: 16368986
[TBL] [Abstract][Full Text] [Related]
22. Anti-adenovirus humoral responses influence on the efficacy of vaccines based on epitope display on adenovirus capsid.
Lanzi A; Ben Youssef G; Perricaudet M; Benihoud K
Vaccine; 2011 Feb; 29(7):1463-71. PubMed ID: 21184856
[TBL] [Abstract][Full Text] [Related]
23. Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
Reyes-Sandoval A; Sridhar S; Berthoud T; Moore AC; Harty JT; Gilbert SC; Gao G; Ertl HC; Wilson JC; Hill AV
Eur J Immunol; 2008 Mar; 38(3):732-41. PubMed ID: 18266272
[TBL] [Abstract][Full Text] [Related]
24. Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice.
Shiratsuchi T; Rai U; Krause A; Worgall S; Tsuji M
J Clin Invest; 2010 Oct; 120(10):3688-701. PubMed ID: 20811151
[TBL] [Abstract][Full Text] [Related]
25. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
[TBL] [Abstract][Full Text] [Related]
26. Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium yoelii.
González-Aseguinolaza G; Nakaya Y; Molano A; Dy E; Esteban M; Rodríguez D; Rodríguez JR; Palese P; García-Sastre A; Nussenzweig RS
J Virol; 2003 Nov; 77(21):11859-66. PubMed ID: 14557672
[TBL] [Abstract][Full Text] [Related]
27. Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.
Nardin EH; Calvo-Calle JM; Oliveira GA; Clavijo P; Nussenzweig R; Simon R; Zeng W; Rose K
Vaccine; 1998 Apr; 16(6):590-600. PubMed ID: 9569470
[TBL] [Abstract][Full Text] [Related]
28. Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites.
Mizutani M; Iyori M; Blagborough AM; Fukumoto S; Funatsu T; Sinden RE; Yoshida S
Infect Immun; 2014 Oct; 82(10):4348-57. PubMed ID: 25092912
[TBL] [Abstract][Full Text] [Related]
29. Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus.
Urakami A; Sakurai A; Ishikawa M; Yap ML; Flores-Garcia Y; Haseda Y; Aoshi T; Zavala FP; Rossmann MG; Kuno S; Ueno R; Akahata W
Clin Vaccine Immunol; 2017 Jul; 24(7):. PubMed ID: 28515133
[TBL] [Abstract][Full Text] [Related]
30. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
Dobaño C; Doolan DL
Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
[TBL] [Abstract][Full Text] [Related]
31. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
[TBL] [Abstract][Full Text] [Related]
32. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
[TBL] [Abstract][Full Text] [Related]
33. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus.
Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R
J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154
[TBL] [Abstract][Full Text] [Related]
34. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
[TBL] [Abstract][Full Text] [Related]
35. CD8+ T effector memory cells protect against liver-stage malaria.
Reyes-Sandoval A; Wyllie DH; Bauza K; Milicic A; Forbes EK; Rollier CS; Hill AV
J Immunol; 2011 Aug; 187(3):1347-57. PubMed ID: 21715686
[TBL] [Abstract][Full Text] [Related]
36. An unstable Th epitope of P. falciparum fosters central memory T cells and anti-CS antibody responses.
Parra-López CA; Bernal-Estévez D; Yin L; Vargas LE; Pulido-Calixto C; Salazar LM; Calvo-Calle JM; Stern LJ
PLoS One; 2014; 9(7):e100639. PubMed ID: 24983460
[TBL] [Abstract][Full Text] [Related]
37. Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP.
Rampling T; Ewer KJ; Bowyer G; Bliss CM; Edwards NJ; Wright D; Payne RO; Venkatraman N; de Barra E; Snudden CM; Poulton ID; de Graaf H; Sukhtankar P; Roberts R; Ivinson K; Weltzin R; Rajkumar BY; Wille-Reece U; Lee CK; Ockenhouse CF; Sinden RE; Gerry S; Lawrie AM; Vekemans J; Morelle D; Lievens M; Ballou RW; Cooke GS; Faust SN; Gilbert S; Hill AV
J Infect Dis; 2016 Sep; 214(5):772-81. PubMed ID: 27307573
[TBL] [Abstract][Full Text] [Related]
38. Efficient induction of protective anti-malaria immunity by recombinant adenovirus.
Rodrigues EG; Zavala F; Nussenzweig RS; Wilson JM; Tsuji M
Vaccine; 1998 Nov; 16(19):1812-7. PubMed ID: 9795385
[TBL] [Abstract][Full Text] [Related]
39. Expression, purification and refolding of a self-assembling protein nanoparticle (SAPN) malaria vaccine.
Guo Q; Dasgupta D; Doll TA; Burkhard P; Lanar DE
Methods; 2013 May; 60(3):242-7. PubMed ID: 23548672
[TBL] [Abstract][Full Text] [Related]
40. Chimeric epitopes delivered by polymeric synthetic linear peptides induce protective immunity to malaria.
Caro-Aguilar I; Lapp S; Pohl J; Galinski MR; Moreno A
Microbes Infect; 2005 Oct; 7(13):1324-37. PubMed ID: 16253535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
